Enric Contreras
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial.
Journal: Vox sanguinis
Published: August 12, 2023
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: September 09, 2021
SARS-CoV-2/COVID-19 pandemic: first wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report.
Journal: Blood transfusion = Trasfusione del sangue
Published: August 02, 2020
Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients.
Journal: Blood transfusion = Trasfusione del sangue
Published: August 01, 2020
2013: The Seville document on consensus on the alternatives to allogenic blood transfusion. Update to the Seville document. Spanish Societies of Anaesthesiology (SEDAR), Haematology and Haemotherapy (SEHH), Hospital Pharmacy (SEFH), Critical Care Medicine (SEMICYUC), Thrombosis and Haemostasis (SETH) and Blood Transfusion (SETS)
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: June 25, 2013
Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".
Journal: Blood transfusion = Trasfusione del sangue
Published: January 28, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026